Drug Trial Radar · NCT05265338
A Food Effect Study of KC1036 in Healthy Subjects
Last checked: Nov 19, 2026Latest source record: Oct 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Actual
Start
Mar 10, 2022
Primary completion
Mar 23, 2022
Study completion Mar 23, 2022
Sponsor
- Lead sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Mar 3, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objective of the study was to assess the effect of High Fat Diet on the pharmacokinetics of KC1036 in Chinese adult healthy subjects.
Conditions
- Healthy Subjects
Interventions
KC1036Drug
60mg QD
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetics (PK) profile: CmaxTime frame: up to 13 Days
- Pharmacokinetics (PK) profile: TmaxTime frame: up to 13 Days
- Pharmacokinetics (PK) profile: T1/2Time frame: up to 13 Days
- Pharmacokinetics (PK) profile: AUCTime frame: up to 13 Days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
West China Hospital of Sichuan University
Chengdu, Sichuan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.